-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HAUdP568650rZd8WLKOG2owK/qSuVcXH87ZcGtvFQcUoUo9/Gez9miCmKnhpn8ul 4aB59dMaxsPAh4/FApaCog== 0000950123-00-003467.txt : 20000411 0000950123-00-003467.hdr.sgml : 20000411 ACCESSION NUMBER: 0000950123-00-003467 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20000410 GROUP MEMBERS: PHARMACIA & UPJOHN AB GROUP MEMBERS: PHARMACIA & UPJOHN HOLDINGS B V GROUP MEMBERS: PHARMACIA & UPJOHN INC GROUP MEMBERS: PHARMACIA CORPORATION SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: INSITE VISION INC CENTRAL INDEX KEY: 0000802724 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943015807 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-42661 FILM NUMBER: 598007 BUSINESS ADDRESS: STREET 1: 445 MARINE VIEW AVE STREET 2: SUITE 100 CITY: DEL MAR STATE: CA ZIP: 92014 BUSINESS PHONE: 5108658800 MAIL ADDRESS: STREET 1: 445 MARINE VIEW AVE STREET 2: SUITE 100 CITY: DEL MAR STATE: CA ZIP: 92014 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACIA & UPJOHN INC CENTRAL INDEX KEY: 0000949573 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980155411 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 100 ROUTE 206 N CITY: PEAPACK STATE: NJ ZIP: 07977 BUSINESS PHONE: 8887685501 MAIL ADDRESS: STREET 1: 7000 PORTGAGE ROAD CITY: KALAMAZOO STATE: MI ZIP: 49001 SC 13G/A 1 AMENDMENT #1 TO SCHEDULE 13G 1 ------------------------------ OMB APPROVAL ------------------------------ OMB Number: 3235-0145 Expires: October 31, 2002 Estimated average burden hours per response 14.90 ------------------------------ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* InSite Vision Incorporated -------------------------- (Name of Issuer) Common Stock, Par Value $0.01 Per Share --------------------------------------- (Title of Class of Securities) 457660 10 8 -------------- (CUSIP Number) March 31, 2000 -------------- Date of Event Which Requires Filing of this Statement Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) [x] Rule 13d-1(c) Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). POTENTIAL PERSONS WHO ARE TO RESPOND TO THE COLLECTION OF INFORMATION CONTAINED IN THIS FORM ARE NOT REQUIRED TO RESPOND UNLESS THE FORM DISPLAYS A CURRENTLY VALID OMB CONTROL NUMBER. 2 SCHEDULE 13G/A - ------------------------- ------------------------- CUSIP No. 457660 10 8 Page 2 of 9 Pages - ------------------------- ------------------------- - ------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). Pharmacia & Upjohn AB - ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] - ------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Sweden - ------------------------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES BENEFICIALLY 1,095,506 OWNED BY ------------------------------------------------------- EACH 6 SHARED VOTING POWER REPORTING PERSON -0- WITH ------------------------------------------------------- 7 SOLE DISPOSITIVE POWER 1,095,506 ------------------------------------------------------- 8 SHARED DISPOSITIVE POWER -0- - ------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,095,506 - ------------------------------------------------------------------------------- 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - ------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.9% - ------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO - ------------------------------------------------------------------------------- 3 SCHEDULE 13G/A - ------------------------- ------------------------- CUSIP No. 457660 10 8 Page 3 of 9 Pages - ------------------------- ------------------------- - ------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). Pharmacia & Upjohn Holdings B.V. - ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] - ------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Netherlands - ------------------------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES BENEFICIALLY 1,095,506 OWNED BY ------------------------------------------------------- EACH 6 SHARED VOTING POWER REPORTING PERSON -0- WITH ------------------------------------------------------- 7 SOLE DISPOSITIVE POWER 1,095,506 ------------------------------------------------------- 8 SHARED DISPOSITIVE POWER -0- - ------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,095,506 - ------------------------------------------------------------------------------- 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - ------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.9% - ------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO - ------------------------------------------------------------------------------- 4 SCHEDULE 13G/A - ------------------------- ------------------------- CUSIP No. 457660 10 8 Page 4 of 9 Pages - ------------------------- ------------------------- - ------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). Pharmacia & Upjohn, Inc. - ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] - ------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - ------------------------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES BENEFICIALLY 1,095,506 OWNED BY ------------------------------------------------------- EACH 6 SHARED VOTING POWER REPORTING PERSON -0- WITH ------------------------------------------------------- 7 SOLE DISPOSITIVE POWER 1,095,506 ------------------------------------------------------- 8 SHARED DISPOSITIVE POWER -0- - ------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,095,506 - ------------------------------------------------------------------------------- 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - ------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.9% - ------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO - ------------------------------------------------------------------------------- 5 SCHEDULE 13G/A - ------------------------- ------------------------- CUSIP No. 457660 10 8 Page 5 of 9 Pages - ------------------------- ------------------------- - ------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). Pharmacia Corporation - ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] - ------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - ------------------------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES BENEFICIALLY 1,095,506 OWNED BY ------------------------------------------------------- EACH 6 SHARED VOTING POWER REPORTING PERSON -0- WITH ------------------------------------------------------- 7 SOLE DISPOSITIVE POWER 1,095,506 ------------------------------------------------------- 8 SHARED DISPOSITIVE POWER -0- - ------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,095,506 - ------------------------------------------------------------------------------- 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - ------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.9% - ------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO, HC - ------------------------------------------------------------------------------- 6 CUSIP Number: 457660 10 8 Page 6 of 9 Pharmacia & Upjohn AB (formerly Pharmacia AB), a Swedish corporation ("P&U AB"), Pharmacia & Upjohn Holdings BV, a "check the box" entity incorporated in the Netherlands ("P&U BV") and Pharmacia & Upjohn, Inc. ("P&U Inc.", and together with P&U AB and P&U BV, the "Original Reporting Persons"), and Pharmacia Corporation (formerly Monsanto Company), a Delaware corporation ("PHA", and together with the Original Reporting Persons the "Reporting Persons") hereby amend the report on Schedule 13G (the "Original Schedule 13G") filed by the Original Reporting Persons on February 26, 1999, with respect to shares of Common Stock, par value $.01 per share, of Insite Vision Incorporated, a Delaware corporation ("Insite"), beneficially owned by them. Capitalized terms used but not defined herein shall have the meaning attributed to such terms in the Original Schedule 13G. On December 19, 1999, P&U Inc., PHA, and MP Sub, Incorporated, a Delaware corporation and a direct wholly owned subsidiary of PHA ("MP Sub") entered into an Agreement and Plan of Merger, as amended (the "Merger Agreement"). On March 31, 2000, pursuant to the Merger Agreement, MP Sub merged (the "Merger") with and into P&U Inc. as a result of which P&U Inc. became a wholly owned subsidiary of PHA. ITEM 2. Item 2 of the Original Schedule 13G is amended in its entirety as follows: (a). Name of Person Filing: P&U AB, P&U BV, P&U Inc. and PHA. (b). Address of Principal Business Office: The principal business address of P&U AB is Pharmacia & Upjohn AB, S-171 97 Stockholm, Sweden. The principal business address of P&U BV is Pharmacia & Upjohn Holdings B.V., Houttuinlaan 4, NL - 3447 GM Woerden, the Netherlands. The principal business address of each of P&U Inc. and PHA is 100 Route 206 North, Peapack, New Jersey 07977. (c). Citizenship: P&U AB, is a Swedish corporation, P&U BV is a "check the box" entity incorporated in the Netherlands, P&U Inc. is a Delaware corporation and PHA is a Delaware corporation. 7 CUSIP Number: 457660 10 8 Page 7 of 9 (d). Title of Class of Securities: Common stock, par value $0.01 per share (the "Shares"). (e). CUSIP Number: 457660 10 8 ITEM 4. Ownership. Item 4 of the Original Schedule 13G is amended in its entirety as follows: (a). P&U AB beneficially owns 1,095,506 Shares. P&U BV, P&U Inc. and PHA may be each deemed to beneficially own 1,095,506 Shares of InSite. (b). The percentage interest held by each Reporting Person presented below is based on the number of Shares reported to be outstanding as of March 27, 2000 in Insite's Annual Report on Form 10-K, for the fiscal year ended December 31, 1999, filed March 30, 2000 (the "Outstanding Shares"). P&U AB beneficially owns approximately 6.9% of the Outstanding Shares. P&U BV, P&U Inc. and PHA may be each deemed to beneficially own approximately 6.9% of the Outstanding Shares. (c). Each Reporting Person has the power to vote or direct the vote and dispose or direct the disposition of the Shares beneficially owned by such Reporting Persons as indicated in pages 2 through 5 above. ITEM 6. Ownership of More than Five Percent on Behalf of Another Person. Not Applicable. 8 CUSIP Number: 457660 10 8 Page 8 of 9 ITEM 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported by the Parent Holding Company. See Exhibit 99.2. ITEM 10. Certification. By signing below we certify that, to the best of our knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. 9 CUSIP Number: 457660 10 8 Page 9 of 9 SIGNATURE After reasonable inquiry and to the best of our knowledge and belief, we certify that the information set forth in this statement is true, complete and correct. Dated: April 10, 2000 PHARMACIA & UPJOHN AB By: /s/ Hakan Astrom ------------------------------- Name: Hakan Astrom Title: Managing Director PHARMACIA & UPJOHN HOLDINGS B.V. By: /s/ Wim Kuiper ------------------------------- Name: Wim Kuiper Title: Director PHARMACIA & UPJOHN, INC. By: /s/ Don W. Schmitz ------------------------------- Name: Don W. Schmitz Title: Secretary PHARMACIA CORPORATION By: /s/ Don W. Schmitz ------------------------------- Name: Don W. Schmitz Title: Secretary 10 INDEX TO EXHIBITS Exhibit No. Exhibit 99.1 Joint Filing Statement, dated April 10, 2000, between Pharmacia & Upjohn AB, Pharmacia & Upjohn Holdings BV, Pharmacia & Upjohn, Inc. and Pharmacia Corporation 99.2 Item 7 Information EX-99.1 2 JOINT FILING STATEMENT 1 EXHIBIT 99.1 JOINT FILING STATEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G/A (including any and all amendments thereto) with respect to the Common Stock, $0.01 par value, of InSite Vision Incorporated, and further agree to the filing of this agreement as an Exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13G/A. Dated: April 10, 2000 PHARMACIA & UPJOHN AB By: /s/ Hakan Astrom -------------------------------- Name: Hakan Astrom Title: Managing Director PHARMACIA & UPJOHN HOLDINGS B.V. By: /s/ Wim Kuiper -------------------------------- Name: Wim Kuiper Title: Director PHARMACIA & UPJOHN, INC. By: /s/ Don W. Schmitz -------------------------------- Name: Don W. Schmitz Title: Secretary PHARMACIA CORPORATION By: /s/ Don W. Schmitz -------------------------------- Name: Don W. Schmitz Title: Secretary EX-99.2 3 ITEM 7 INFORMATION 1 EXHIBIT 99.2 ITEM 7 INFORMATION The securities being reported on by PHA, are all owned by P&U AB which is a wholly owned subsidiary of P&U BV. P&U BV is a wholly owned subsidiary of P&U Inc. P&U Inc. is a wholly owned subsidiary of PHA. -----END PRIVACY-ENHANCED MESSAGE-----